Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News

April 24, 2026 — Johnson & Johnson recently announced the initiation of the PERSIGMA randomized controlled trial (RCT) ...

Home April 27, 2026
Home
News | Pacemakers

April 24, 2026 — A new analysis from the NOAH – AFNET 6 trial shows that artificial intelligence (AI) can help unlock ...

Home April 24, 2026
Home
News | HRS

April 24, 2026The Heart Rhythm Society has announced the first analysis of its Centers of Excellence Optimal ...

Home April 24, 2026
Home
News | HRS

April 23, 2026 — A new study analyzing data from more than 13,000 patients found that people using the increasingly ...

Home April 23, 2026
Home
News | Atrial Fibrillation

April 13, 2026 — Heart failure is common in people who have atrial fibrillation detected during screening, according to ...

Home April 14, 2026
Home
News

April 13, 2026 — Johnson & Johnson has announced favorable 12-month interim effectiveness and safety results from ...

Home April 13, 2026
Home
News | Atrial Fibrillation

April 2, 2026 — Omron Healthcare Co. has launched a randomized controlled trial in collaboration with the University of ...

Home April 03, 2026
Home
News | Atrial Fibrillation

Feb. 9, 2026 — Argá Medtech has announced positive clinical results from the BURST-AF (NCT05572047) first-in-human trial ...

Home February 09, 2026
Home
News | Atrial Fibrillation

Feb. 9, 2026 — Atraverse Medical presented new clinical and preclinical data at AF Symposium 2026 in Boston, further ...

Home February 09, 2026
Home
News

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston  ...

Home February 06, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News

Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...

Home January 22, 2026
Home
News

Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...

Home January 21, 2026
Home
News | Atrial Fibrillation

Dec. 19, 2025 — Johnson & Johnson MedTech has announced its sponsorship of a new data collection platform developed by ...

Home December 19, 2025
Home
Digital Tools Provide Insight into AFib
Feature | Atrial Fibrillation | Jeffrey Olgin, M.D.

Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable ...

Home September 12, 2025
Home
Subscribe Now